Ensitrelvir is a highly effective drug to treat COVID, and early data show patients who take it produce negative test results 36 hours faster than those who take a placebo. But as Rachel Gutman-Wei writes in the Atlantic, while the drug is available in Japan, Americans may not have access to it for a year as it remains in clinical trials demanded by U.S. regulators. |